Coherus Biosciences Inc (CHRS)

08:01 AM

Coherus BioSciences Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

08:01 AM

Mar 13, 2025

Coherus Prepares To Wave Goodbye To Udenyca – And 30% Of Its Staff - Citeline News & Insights

Mar 13, 2025

Mar 13, 2025

Coherus BioSciences Shareholders Approve UDENYCA Franchise Sale - Investing.com

Mar 13, 2025

Mar 12, 2025

Coherus BioSciences, Inc. (CHRS): A Bull Case Theory - Insider Monkey

Mar 12, 2025

Mar 12, 2025

Coherus BioSciences (NASDAQ:CHRS) Receives “Buy” Rating from HC Wainwright - Defense World

Mar 12, 2025

Mar 11, 2025

Coherus BioSciences’ Earnings Call: Growth and Challenges - TipRanks

Mar 11, 2025

Mar 11, 2025

Coherus Biosciences: Strategic Divestment and Pipeline Focus Justify Buy Rating - TipRanks

Mar 11, 2025

Mar 11, 2025

Coherus stock rating upgraded on Loqtorzi sales growth By Investing.com - Investing.com Australia

Mar 11, 2025

Mar 11, 2025

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 11, 2025

Mar 11, 2025

Earnings call transcript: Coherus BioSciences Q4 2024 sees revenue beat By Investing.com - Investing.com Canada

Mar 11, 2025

Mar 11, 2025

Coherus BioSciences Inc (CHRS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Mar 11, 2025

Mar 11, 2025

Coherus BioSciences Inc (CHRS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Transition - GuruFocus.com

Mar 11, 2025

Mar 10, 2025

Coherus BioSciences earnings beat by $0.02, revenue topped estimates - Investing.com Canada

Mar 10, 2025

Mar 10, 2025

Earnings call transcript: Coherus BioSciences Q4 2024 sees revenue beat - Investing.com

Mar 10, 2025

Mar 10, 2025

Coherus BioSciences: Q4 Earnings Snapshot - mySA

Mar 10, 2025

Mar 10, 2025

Coherus BioSciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 10, 2025

Mar 10, 2025

Coherus Biosciences, Inc. Q4 Loss Narrows - Nasdaq

Mar 10, 2025

Mar 10, 2025

Coherus BioSciences Q4 Net Loss Narrows, Revenue Declines -March 10, 2025 at 04:47 pm EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Coherus BioSciences Q4 revenue tops estimates, shares edge higher By Investing.com - Investing.com South Africa

Mar 10, 2025

Mar 10, 2025

Coherus BioSciences Q4 revenue tops estimates, shares edge higher - Investing.com India

Mar 10, 2025

Mar 10, 2025

Coherus BioSciences: Q4 Earnings Snapshot -March 10, 2025 at 04:33 pm EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

COHERUS BIOSCIENCES Earnings Results: $CHRS Reports Quarterly Earnings - Nasdaq

Mar 10, 2025

Mar 10, 2025

Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 10, 2025

Mar 10, 2025

Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides ... - Bluefield Daily Telegraph

Mar 10, 2025

Mar 10, 2025

Coherus Biotech Revenue Hits $267M, Plans Major Oncology Pivot - StockTitan

Mar 10, 2025

Mar 10, 2025

Sandoz Suggests Coherus’ Cimerli Strategy Was ‘Unsustainable’ - News & Insights

Mar 10, 2025

Mar 07, 2025

What To Expect From Coherus BioSciences Inc (CHRS) Q4 2024 Earni - GuruFocus.com

Mar 07, 2025

Mar 07, 2025

What To Expect From Coherus BioSciences Inc (CHRS) Q4 2024 Earnings - Yahoo Finance

Mar 07, 2025

Mar 07, 2025

New York State Common Retirement Fund Sells 90,585 Shares of Coherus BioSciences, Inc. (NASDAQ:CHRS) - Defense World

Mar 07, 2025

Mar 06, 2025

Coherus BioSciences, Inc. to Host Earnings Call - ACCESS Newswire

Mar 06, 2025

Mar 06, 2025

Coherus BioSciences at TD Cowen Conference: Strategic Oncology Shift - Investing.com

Mar 06, 2025

Mar 05, 2025

Coherus BioSciences (CHRS) Expected to Announce Earnings on Monday - Defense World

Mar 05, 2025

Mar 04, 2025

Institutional owners may consider drastic measures as Coherus BioSciences, Inc.'s (NASDAQ:CHRS) recent US$17m drop adds to long-term losses - Simply Wall St

Mar 04, 2025

Mar 04, 2025

Coherus BioSciences announces supplemental disclosures By Investing.com - Investing.com South Africa

Mar 04, 2025

Mar 04, 2025

Coherus BioSciences announces supplemental disclosures - Investing.com

Mar 04, 2025

Mar 03, 2025

Coherus to Report Fourth Quarter and Full Year 2024 Financial Results on March 10, 2025 - GlobeNewswire

Mar 03, 2025

Mar 03, 2025

CHRSCoherus Bioscien Latest Stock News & Market Updates - StockTitan

Mar 03, 2025

Mar 03, 2025

Coherus BioSciences to Release Q4 and Full Year 2024 Financial Results on March 10, 2025 - Nasdaq

Mar 03, 2025

Mar 03, 2025

When Will Coherus Reveal Its 2024 Performance? Key Date for Biotech Investors - StockTitan

Mar 03, 2025

Feb 27, 2025

Investor Network: Coherus BioSciences, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

With 59% institutional ownership, Coherus BioSciences, Inc. (NASDAQ:CHRS) is a favorite amongst the big guns - Yahoo Canada Finance

Feb 27, 2025

Feb 25, 2025

Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference - GlobeNewswire

Feb 25, 2025

Feb 24, 2025

Can Coherus Management Reveal New Strategic Plans at TD Cowen Conference? - StockTitan

Feb 24, 2025

Feb 24, 2025

Coherus Management To Participate At The 45th Annual TD Cowen Health Care Conference - Barchart

Feb 24, 2025

Feb 17, 2025

Psoriasis Biosimilars Market Top Players- Merck KGaA, Coherus - openPR

Feb 17, 2025

Feb 11, 2025

Coherus BioSciences Reports Fourth Quarter and Full Year 2016 Corporate Highlights and Financial Results - br.ADVFN.com

Feb 11, 2025